日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

一项针对局部晚期头颈癌患者的II期随机试验,比较了放射治疗、西妥昔单抗和培美曲塞联合或不联合贝伐珠单抗的疗效。

Argiris, A; Bauman, J E; Ohr, J; Gooding, W E; Heron, D E; Duvvuri, U; Kubicek, G J; Posluszny, D M; Vassilakopoulou, M; Kim, S; Grandis, J R; Johnson, J T; Gibson, M K; Clump, D A; Flaherty, J T; Chiosea, S I; Branstetter, B; Ferris, R L

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

对高危头颈癌切除患者进行术后放疗联合顺铂加帕尼单抗治疗的 II 期试验

Ferris R L, Geiger J L, Trivedi S, Schmitt N C, Heron D E, Johnson J T, Kim S, Duvvuri U, Clump D A, Bauman J E, Ohr J P, Gooding W E, Argiris A